CARBOGEN AMCIS exists to provide innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries that enable customers to bring new generation medicines to market.
We are dedicated to helping pharmaceutical and biopharmaceutical companies
reduce the time, cost and risks associated with drug development. We combine the
world-class chemistry skills of CARBOGEN AMCIS to provide seamless development and commercialization services for leading pharmaceutical and biotechnology companies.
For our clients’ benefit, we have integrated the early phase process research, rapid supply of APIs and aseptic dosage forms and combined with the late phase and commercial supply. Our Highly Potent API Supply Services, Chromatography Services and Analytical Services and Formulation Services are available as part of our end-to-end core services or on a stand-alone basis.
In today’s high-pressure, time-sensitive drug development climate, we focus on helping clients reduce the time it takes to bring a drug to market. Our cutting-edge communication systems, project management techniques and information technology platforms are effectively integrated to ensure the completion of projects efficiently and effectively.
Our staff comprises more than 300 dedicated chemists, approximately 40 percent of whom hold a Ph.D. in chemistry. We provide all staff members with the highest caliber of continuous training to ensure we stay at the forefront of the latest industry trends throughout our organization.
The integrated services of CARBOGEN AMCIS AG provide innovative, timely and safe drug development solutions that allow customers to make the best use of their available resources. Senior management is proud to play an important role in delivering new therapeutic treatments to patients more safely, quickly and cost-efficiently than ever before.
CARBOGEN AMCIS has a Senior Management Team composed of several highly experienced individuals.
| Chief Executive Officer: | Mark C. Griffiths |
| VP Commercial: | Pascal Villemagne |
| Director High Potency Division: | Charlie Johnson |
| Director Operations: | Dr. Stephan Fritschi |
| Director Technology & SC: | Dr. Alan Fischer |
| Director HR & Support: | Dieter Thüer |
| Director Q & ESH: | Dr. Martin Schneider |
| Head of Finance: | Stephan Rohrer |
| Plant Manager / Qualified Person: | Marc Bertaud, Pharm. D. |
